Promoting effect of borneol on the permeability of puerarin eye drops and timolol maleate eye drops through the cornea in vitro.
Studies on the influence of borneol on the penetration of puerarin eye drops and timolol maleate eye drops through the cornea, and evaluation of the ocular irritability were conducted to provide a theoretical basis for the application of borneol in enhancing corneal permeability. The cornea penetrative experiment in vitro was conducted to observe the quantitative change of puerarin and timolol maleate penetrated through the cornea after administering different dosages of borneol. The corneal hydration level and blinking frequency were recorded as irritability indexes in vitro and in vivo. The steady-flow J of high, middle and low dosage groups of puerarin eye drops with borneol were increased by 49%, 32%, 5% respectively, and permeability parameter Kp increased by 49%, 32%, 5% respectively, as compared to that of the control group. The steady-flow J of high dosage group of timolol maleate eye drops with borneol was increased by 5%; middle and low dosage groups with borneol were decreased by 6%, 3% respectively. The permeability parameter Kp of high dosage group increased by 5%, while middle and low dosage groups with borneol were decreased by 6%, 3% respectively, as compared to that of the control group. Evaluation showed no ocular irritability caused by borneol. The results of this study suggest that the promoting effect of borneol on the permeability of drugs through the cornea in vitro is selective, which indicates that borneol has the potential to be used as an ophthalmic penetration enhancer.
Wu
Chun-jie
CJ
West China School of Pharmacy, Sichuan University, Chengdu, PR China.
Huang
Qin-wan
QW
Qi
Hong-yi
HY
Guo
Ping
P
Hou
Shi-xiang
SX
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D000465:Algorithms; D000818:Animals; D001767:Blinking / Q000187:drug effects; D001892:Camphanes / Q000009:adverse effects / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D003315:Cornea / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D004337:Drug Carriers; D005260:Female; D066298:In Vitro Techniques; D007509:Irritants; D007529:Isoflavones / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D008297:Male; D009883:Ophthalmic Solutions; D010539:Permeability / Q000187:drug effects; D011817:Rabbits; D012015:Reference Standards; D015203:Reproducibility of Results; D013999:Timolol / Q000008:administration & dosage* / Q000493:pharmacokinetics*
D000319:Adrenergic beta-Antagonists; D001892:Camphanes; D004337:Drug Carriers; D007509:Irritants; D007529:Isoflavones; D009883:Ophthalmic Solutions; D013999:Timolol; C022871:isoborneol; C033607:puerarin